The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group
Open accessAbstract
Extranodal lymphomas (ENLs) comprise about a third of all non-Hodgkin lymphomas (NHL). Radiation therapy (RT) is frequently used as either primary therapy (particularly for indolent ENL), consolidation after systemic therapy, salvage treatment, or palliation. The wide range of presentations of ENL, involving any organ in the body and the spectrum of histological sub-types, poses a challenge both for routine clinical care and for the conduct of prospective and retrospective studies. This has led to uncertainty and lack of consistency in RT approaches between centers and clinicians. Thus far there is a lack of guidelines for the use of RT in the management of ENL. This report presents an effort by the International Lymphoma Radiation Oncology Group (ILROG) to harmonize and standardize the principles of treatment of ENL, and to address the technical challenges of simulation, volume definition and treatment planning for the most frequently involved organs. Specifically, detailed recommendations for RT volumes are provided. We have applied the same modern principles of involved site radiation therapy as previously developed and published as guidelines for Hodgkin lymphoma and nodal NHL. We have adopted RT volume definitions based on the International Commission on Radiation Units and Measurements (ICRU), as has been widely adopted by the field of radiation oncology for solid tumors. Organ-specific recommendations take into account histological subtype, anatomy, the treatment intent, and other treatment modalities that may be have been used before RT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Au, W.-Y., Weisenburger, D. D., Intragumtornchai, T., Nakamura, S., Kim, W.-S., Sng, I., Vose, J., Armitage, J. O., Liang, R., & for the International Peripheral T-Cell Lymphoma Project (2009) · Blood · doi:10.1182/blood-2008-10-185256 · Cited by 736
Treatment for Primary CNS Lymphoma: The Next Step
Abrey, L. E., Yahalom, J., & DeAngelis, L. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.17.3144 · Cited by 607
Self-citationSpecht, L., Yahalom, J., Illidge, T., Berthelsen, A. K., Constine, L. S., Eich, H. T., Girinsky, T., Hoppe, R. T., Mauch, P., Mikhaeel, N. G., et al. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2013.05.005 · Cited by 582
Self-citationMorris, P. G., Correa, D. D., Yahalom, J., Raizer, J. J., Schiff, D., Grant, B., Grimm, S., Lai, R. K., Reiner, A. S., Panageas, K., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.4910 · Cited by 500
Self-citationReduced dose radiotherapy for local control in non-Hodgkin lymphoma: A randomised phase III trial
Lowry, L., Smith, P., Qian, W., Falk, S., Benstead, K., Illidge, T., Linch, D., Robinson, M., Jack, A., & Hoskin, P. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.05.013 · Cited by 386
Self-citationKim, S. J., Kim, K., Kim, B. S., Kim, C. Y., Suh, C., Huh, J., Lee, S.-W., Kim, J. S., Cho, J., Lee, G.-W., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.8592 · Cited by 342
Illidge, T., Specht, L., Yahalom, J., Aleman, B., Berthelsen, A. K., Constine, L., Dabaja, B., Dharmarajan, K., Ng, A., Ricardi, U., et al. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.01.006 · Cited by 314
Self-citationGrégoire, V., & Mackie, T. R. (2011) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2011.04.003 · Cited by 305
Delayed Neurotoxicity in Primary Central Nervous System Lymphoma
Omuro, A. M. P., Ben-Porat, L. S., Panageas, K. S., Kim, A. K., Correa, D. D., Yahalom, J., DeAngelis, L. M., & Abrey, L. E. (2005) · Archives of Neurology · doi:10.1001/archneur.62.10.1595 · Cited by 286
Self-citationSmith, J. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)01125-9 · Cited by 277
Cited by
Yahalom, J., Dabaja, B. S., Ricardi, U., Ng, A., Mikhaeel, N. G., Vogelius, I. R., Illidge, T., Qi, S., Wirth, A., & Specht, L. (2020) · Blood · doi:10.1182/blood.2020006028 · Cited by 111
Self-citation
Metadata
- Authors
- Yahalom, J., Illidge, T., Specht, L., Hoppe, R. T., Li, Y.-X., Tsang, R., & Wirth, A.
- Venue
- International Journal of Radiation Oncology*Biology*Physics
- Publisher
- Elsevier BV
- Published
- 2015-05
- Volume
- 92
- Issue
- 1
- Pages
- 11-31
- ISSN
- 0360-3016 (ISSN-L)
- OpenAlex
- W2092939241
- Cited by
- 405
- References
- 22
- FWCI
- 25.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group. https://app.cochat.ai/papers/10.1016/j.ijrobp.2015.01.009
- The paper
- Yahalom, J., Illidge, T., Specht, L., Hoppe, R. T., Li, Y.-X., Tsang, R., & Wirth, A. (2015). Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2015.01.009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
